Brainsway Ltd. Sponsored ADR

BWAY Healthcare Medical Devices

Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

11.41 0.41 −3.47%
Market cap
$475.8M
P/E
24.8×
Fwd P/E
0.0×
Dividend yield
—
F-score
6/9
Altman Z
2.82
Beneish M
−2.45
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 6 7 6
ROE
10.95% 11.18% 12.55% 12.82%
ROA
6.75% 7.30% 8.06% 8.09%
ROIC
0.00% 71.48% 22.79% 29.98%
Return on Tangible Assets
10.82% 12.19% 15.65% 15.84%
Average Days of Receivables
38.13 28.73 48.89 42.29
Free Cash Flow per Share
0.47 0.80 0.61 0.30
Free Cash Flow
18.34 15.15 11.58 5.79
Other line items

Show all line items

Columns are period end dates